BioNTech SE (BNTX)
102.92
+0.80
(+0.78%)
USD |
NASDAQ |
Apr 17, 16:00
102.77
-0.15
(-0.15%)
After-Hours: 20:00
BioNTech Research and Development Expense (Quarterly) : 588.25M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 3.725B |
| GSK Plc | 3.112B |
| Merck & Co., Inc. | 2.499B |
| Novavax, Inc. | 73.98M |
| Moderna, Inc. | 708.00M |